31 Jan 2019 Valneva Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate
30 Jan 2019 Merck Receives Breakthrough Therapy Designation from FDA for V114, the Company’s Investigational 15-Valent Conjugate Vaccine for the Prevention of Invasive Pneumococcal Disease, in Infants, Children, and Adolescents
29 Jan 2019 Takeda’s Dengue Vaccine Candidate Meets Primary Endpoint in Pivotal Phase 3 Efficacy Trial
24 Jan 2019 Advaxis’ Phase 3 AIM2CERV Study Placed on Partial Clinical Hold by FDA Related to CMC Requests
24 Jan 2019 Bavarian Nordic Advances Development of Equine Encephalitis Virus Vaccine
21 Jan 2019 ISA Pharmaceuticals Announces Start of Phase 2 Combination Trial of ISA101b and Regeneron’s Cemiplimab in Oropharyngeal Cancer
17 Jan 2019 United Neuroscience Announces Positive Top-Line Results from Phase 2a Clinical Study of UB-311 Vaccine in Patients with Alzheimer's Disease
17 Jan 2019 AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial
17 Jan 2019 First Patient Dosed in Phase 1 Clinical Trial Evaluating Neoepitopes Formulated in IMV’s DPX Delivery Platform in Ovarian Cancer Patients
15 Jan 2019 FDA Approves Expanded Use of Adacel® (Tdap) Vaccine for Repeat Vaccination
08 Jan 2019 PrimeVax Immuno-Oncology Receives IND Permission From FDA
07 Jan 2019 Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate
03 Jan 2019 Genocea Doses First Patients and Completes Enrollment in Part A of Phase 1/2a Clinical Trial for Neoantigen Vaccine Candidate GEN-009
30 Dec 2018 Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThrax
27 Dec 2018 FDA Approves VAXELIS(TM), Sanofi and MSD's Pediatric Hexavalent Combination Vaccine
22 Dec 2018 Aimmune Therapeutics Submits BLA to FDA for AR101 for the Treatment of Peanut Allergy in Children and Adolescents Ages 4–17
22 Dec 2018 Bavarian Nordic Announces FDA Acceptance and Priority Review of Biologics License Application for MVA-BN Smallpox Vaccine
21 Dec 2018 Independent Data Monitoring Committee Recommends Discontinuation of the Phase 2b STRIVE Clinical Trial of Staphylococcus aureus Vaccine Following Planned Interim Analysis
20 Dec 2018 Aimmune Therapeutics Announces IND Filing for AR201 for Egg Allergy and Exclusive Supply Agreement with Michael Foods
20 Dec 2018 HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus
20 Dec 2018 Aimmune Therapeutics Initiates Phase 3 POSEIDON Trial for Treatment of Peanut Allergy in 1–3-Year-Old Children
20 Dec 2018 ILiAD Biotechnologies Secures Up to $20 million of Financing and Phase 2a BPZE1 Pertussis Vaccine Trial Initiates at Vanderbilt University Medical Center
19 Dec 2018 Dengvaxia® vaccine approved for prevention of dengue in Europe
17 Dec 2018 Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate
15 Dec 2018 VAXIMM Initiates Phase I/II Trial with VXM01 Oral T-cell Immunotherapy in Combination with PD-L1 Inhibitor Avelumab in Glioblastoma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up